A Dobrut, M Brzychczy-Włoch - Pathogens, 2021 - mdpi.com
Streptococcus agalactiae (Group B Streptococcus, GBS) is an opportunistic pathogen, which asymptomatically colonizes the gastrointestinal and genitourinary tract of up to one third of …
L Wu, AN Dammann, AJ Ratner - Molecular Medical Microbiology, 2024 - Elsevier
Streptococcus agalactiae (group B Streptococcus, GBS) is an important perinatal pathogen and an emerging etiology of disease in nonpregnant adults. Despite decades of control …
A Dobrut, D Ochońska, E Brzozowska… - Frontiers in …, 2022 - frontiersin.org
Group B streptococcus (GBS) is one of the uropathogens that causes urinary tract infections (UTIs). The aims of this article were molecular characterization, an analysis of antimicrobial …
J Wang, W Li, N Li, B Wang - Vaccines, 2023 - mdpi.com
Group B streptococcus (GBS) commonly colonizes the vaginal tract and is a leading cause of life-threatening neonatal infections and adverse pregnancy outcomes. No effective …
L Shen, M Huang, N Xie - Cellular and Molecular Biology, 2021 - cellmolbiol.org
This study aimed to evaluate Streptococcus agalactiae genotype and erythromycin resistance in neonatal sepsis. After obtaining the mothers' informed consent, trained nurses …
SM Soto, S Payot, IG Est-Nancy, FM Korir - portalwiedzy.cm-uj.krakow.pl
Dobrut et al. Characterization of GBS From UTI potential immunodiagnostic markers. Although the examined GBS isolates showed high genetic diversity, immunoreactive …